2009
DOI: 10.4161/auto.5.3.7491
|View full text |Cite
|
Sign up to set email alerts
|

The expression ofbeclin 1is associated with favorable prognosis in stage IIIB colon cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

17
128
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 136 publications
(145 citation statements)
references
References 17 publications
17
128
0
Order By: Relevance
“…Experiments in vitro had reported that Beclin-1 could be as a reliable marker in monitoring the prognosis in CRC. However, conflicting results have been also reported from different laboratories (Guo et al, 2011;Li et al, 2009). In our meta-analysis, higher Beclin-1 expression was positively linked to tumor distant metastasis, which was also confirmed by Ahn's study (Ahn et al, 2007).…”
Section: Discussionmentioning
confidence: 73%
See 2 more Smart Citations
“…Experiments in vitro had reported that Beclin-1 could be as a reliable marker in monitoring the prognosis in CRC. However, conflicting results have been also reported from different laboratories (Guo et al, 2011;Li et al, 2009). In our meta-analysis, higher Beclin-1 expression was positively linked to tumor distant metastasis, which was also confirmed by Ahn's study (Ahn et al, 2007).…”
Section: Discussionmentioning
confidence: 73%
“…Similar studies also demonstrated that over-expression of Beclin-1 inhabited colorectal cancer cell growth (Chen et al, 2013), and the higher level of Beclin-1 was strongly associated with longer survival (Li et al, 2009). So no certainty outcomes were determined up to now.…”
Section: Introductionmentioning
confidence: 69%
See 1 more Smart Citation
“…In human colon cancer tissue observed via immunohistochemistry, Beclin 1 is distributed within the plasmamembrane, the cytoplasm and the nucleus. 11 Beclin 1 contains three identified structural domains: a BH3 domain (amino acids 114-123) at the N-terminus, a central coiled-coil domain (CCD, amino acids 144-269) and an evolutionarily conserved domain (ECD, amino acids 244-337) (Figure 2a). The ECD is essential for Beclin 1's ability to mediate autophagy and to inhibit tumorigenesis.…”
Section: Beclin 1 Is a Bh3-only Domain Autophagy Proteinmentioning
confidence: 99%
“…In addition, beclin-1 is a haploinsufficient tumor suppressor gene in mice, because loss of one beclin-1 allele in mice was shown to lead to a high incidence of lung and hepatocellular carcinomas, lymphomas, as well as mammary neoplastic lesions (30,31). Also importantly, decreased Beclin-1 expression was found to be strongly associated with reduced survival rate of stage IIIB colon cancer patients (32). Furthermore, increased Beclin-1 expression was demonstrated to block anchorage-independent growth and in vivo tumorigenicity of human breast carcinoma cells (33).…”
mentioning
confidence: 99%